Literature DB >> 21624547

Prenatal diagnosis of hypoplastic left heart syndrome in current era.

Alaina K Kipps1, Colin Feuille, Anthony Azakie, Julien I E Hoffman, Sarah Tabbutt, Michael M Brook, Anita J Moon-Grady.   

Abstract

We sought to evaluate the relation of a prenatal diagnosis (preDx) with morbidity and mortality during the initial hospitalization in a contemporary cohort of patients with hypoplastic left heart syndrome (HLHS). A retrospective study of patients with HLHS presenting from 1999 to 2010 was performed. Patients with genetic disorders or a gestational age <34 weeks or who had intentionally received comfort care only were excluded. Of the 81 patients meeting the study criteria, 49 had a preDx and 32 were diagnosed postnatally (postDx). Birth weight (median 3.0 vs 3.4 kg; p = 0.007) and gestational age (median 38 vs 39 weeks; p <0.001) were lower in the preDx than in the postDx patients. Preoperatively, the postDx patients were intubated more frequently (97% vs 71%, p = 0.004) and ventilated longer (median 96 vs 24 hours, p = 0.005) than the preDx patients. They also had more preoperative acidosis, multiorgan failure, tricuspid valve regurgitation, and right ventricular dysfunction. Of the 73 patients undergoing surgery, no difference in survival was seen between the preDx and postDx groups (91% vs 89%). The median duration of postoperative ventilation was 7 days and the median length of stay was 36 days for the 66 survivors, with no difference between the 2 groups. Postoperative morbidities, including chylothorax and infection, were also similar in the preDx and postDx patients. No studied preoperative factor was associated with death, duration of postoperative ventilation, or length of stay. In conclusion, our recent experience has shown that preDx of HLHS was not associated with a survival advantage, fewer postoperative complications, or shorter length of stay. Improved preoperative status was observed in the preDx patients; however, they were born earlier with a lower birthweight. What effect these factors might have on longer term morbidity remains unknown.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21624547     DOI: 10.1016/j.amjcard.2011.03.065

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  18 in total

Review 1.  Prenatal Counseling of Fetal Congenital Heart Disease.

Authors:  Caroline K Lee
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-01

2.  Association of Prenatal Diagnosis of Critical Congenital Heart Disease With Postnatal Brain Development and the Risk of Brain Injury.

Authors:  Shabnam Peyvandi; Veronica De Santiago; Elavazhagan Chakkarapani; Vann Chau; Andrew Campbell; Kenneth J Poskitt; Duan Xu; A James Barkovich; Steven Miller; Patrick McQuillen
Journal:  JAMA Pediatr       Date:  2016-04-04       Impact factor: 16.193

3.  Low rate of prenatal diagnosis among neonates with critical aortic stenosis: insight into the natural history in utero.

Authors:  L R Freud; A Moon-Grady; M C Escobar-Diaz; N L Gotteiner; L T Young; D B McElhinney; W Tworetzky
Journal:  Ultrasound Obstet Gynecol       Date:  2015-01-28       Impact factor: 7.299

4.  Timing and Mode of Delivery in Prenatally Diagnosed Congenital Heart Disease- an Analysis of Practices within the University of California Fetal Consortium (UCfC).

Authors:  Shabnam Peyvandi; Tina Ahn Thu Thi Nguyen; Myriam Almeida-Jones; Nina Boe; Laila Rhee; Tracy Anton; Mark Sklansky; Maryam Tarsa; Gary Satou; Anita J Moon-Grady
Journal:  Pediatr Cardiol       Date:  2017-01-11       Impact factor: 1.655

5.  A Prospective Study of the Use of Fetal Intelligent Navigation Echocardiography (FINE) to Obtain Standard Fetal Echocardiography Views.

Authors:  Paola Veronese; Gianna Bogana; Alessia Cerutti; Lami Yeo; Roberto Romero; Maria Teresa Gervasi
Journal:  Fetal Diagn Ther       Date:  2016-06-17       Impact factor: 2.587

6.  Impact of prenatal diagnosis in survivors of initial palliation of single ventricle heart disease: analysis of the National Pediatric Cardiology Quality Improvement Collaborative database.

Authors:  David W Brown; Katie E Cohen; Patricia O'Brien; Kimberlee Gauvreau; Thomas S Klitzner; Robert H Beekman; John D Kugler; Gerard R Martin; Steven R Neish; Geoffrey L Rosenthal; Carole Lannon; Kathy J Jenkins
Journal:  Pediatr Cardiol       Date:  2014-08-19       Impact factor: 1.655

7.  Trends in Preterm Delivery among Singleton Gestations with Critical Congenital Heart Disease.

Authors:  Daniel A Castellanos; Keila N Lopez; Jason L Salemi; Alireza A Shamshirsaz; Yunfei Wang; Shaine A Morris
Journal:  J Pediatr       Date:  2020-07       Impact factor: 4.406

8.  A population-based study of the association of prenatal diagnosis with survival rate for infants with congenital heart defects.

Authors:  Matthew E Oster; Christopher H Kim; Aaron S Kusano; Janet D Cragan; Paul Dressler; Alice R Hales; William T Mahle; Adolfo Correa
Journal:  Am J Cardiol       Date:  2013-12-27       Impact factor: 2.778

9.  Prenatal diagnosis, birth location, surgical center, and neonatal mortality in infants with hypoplastic left heart syndrome.

Authors:  Shaine A Morris; Mary K Ethen; Daniel J Penny; Mark A Canfield; Charles G Minard; David E Fixler; Wendy N Nembhard
Journal:  Circulation       Date:  2013-10-17       Impact factor: 29.690

10.  The significance of an integrated management mode of prenatal diagnosis-postnatal treatment for critical congenital heart disease in newborns.

Authors:  Xiaohui Zhang; Shaoru He; Yumei Liu; Jing Zhong; Yunxia Sun; Manli Zheng; Juan Gui; Ruixi Wang; Bowen Feng; Jianling Mo; Minqiao Jian; Caisheng Liu; Yijing Liang
Journal:  Cardiovasc Diagn Ther       Date:  2021-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.